Format

Send to

Choose Destination
Semin Perinatol. 2018 Mar;42(2):80-88. doi: 10.1053/j.semperi.2017.12.003. Epub 2018 Jan 2.

Current trends in neonatal ECMO.

Author information

1
Department of Pediatrics, Division of Newborn Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, One Children's Hospital Dr, 2133 Faculty Pavilion, 4401 Penn Ave, Pittsburgh, PA 15224. Electronic address: bmahmood@mail.magee.edu.
2
Extracorporeal Support Department, Children's Mercy Kansas City, Kansas City, MO.
3
Extracorporeal Support Department, Children's Mercy Kansas City, Kansas City, MO; Department of Pediatrics, University of Missouri School of Medicine, Intensive Care Nursery and Neonatal ECMO Children's Mercy, Kansas City, MO.

Abstract

Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy for patients with respiratory and cardiac failure refractory to maximal medical management. The extracorporeal life support organization registry is the largest available resource for describing the population and outcomes of patients treated with this therapy. The use of ECMO for neonatal patients is decreasing in proportion to the total annual ECMO runs most likely due to advancements in medical management. Although the overall survival for neonatal ECMO has decreased, this is likely a reflection of the increasingly complex neonatal patients treated with this therapy. Although many patient and mechanical complications are decreasing over time, there remains a high percentage of morbidities and risks associated with ECMO. Continued refinements in management strategies are important to improving overall patient outcomes.

KEYWORDS:

Developmental outcomes; ECMO modes; Equipment trends; Mechanical complications; Neonatal cardiac ECMO; Neonatal respiratory ECMO; Patient complications; Patient survival

PMID:
29305227
DOI:
10.1053/j.semperi.2017.12.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center